Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Onken, Jane E.
Jumbo Large Regular Text:
Print
Physicians

Jane E. Onken, MD, MHS

Related Content

Services

  • Colon, Rectal, and Anal Disorders
  • Colonoscopy
  • Gastric (Stomach) Disorders
  • Small Intestine and Appendix Disorders
  • Upper Endoscopy

Share

Jane E. Onken, MD, MHS

Department / Division
Medicine / Medicine - Gastroenterology

Address
DUMC 3902
Durham, NC 27710

Appointment Telephone
919-684-6437

Office Telephone
919-684-1817

Fax Telephone
919-479-2664

Training
  • MD, George Washington University School of Medicine and Health Sciences (Washington, DC), 1987

Residency
  • Internal Medicine, Duke University Medical Center, 1987-1990

Fellowship
  • Gastroenterology, Duke University Medical Center, 1990-1993

Other Training
  • MHS, Duke University, 2005

Clinical Interests
Inflammatory bowel disease, diagnostic and therapeutic endoscopy, GI bleeding, clinical research

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • Abbott Laboratories
  • Bristol-Myers Squibb
  • Centocor Ortho Biotech (J&J)
  • GlaxoSmithKline
  • Luitpold Pharmaceuticals, Inc (Daiichi Sankyo Co)
  • Marathon
  • Schering-Plough Corp. (owned by Merck & Co, USA)
  • Wyeth (Pfizer)

Representative Publications
Provenzale, D; Onken, JE. TPMT genotype screening for patients about to begin azathioprine treatment--a look at costs and potential benefits. Inflammatory Bowel Diseases. 2005;11:1119-1120. (2005) Abstract

Sands, BE; Anderson, FH; Bernstein, CN; Chey, WY; Feagan, BG; Fedorak, RN; Kamm, MA; Korzenik, JR; Lashner, BA; Onken, JE; Rachmilewitz, D; Rutgeerts, P; Wild, G; Wolf, DC; Marsters, PA; Travers, SB; Blank, MA; van Deventer, SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. New England Journal of Medicine. 2004;350:876-885. (2004) Abstract

Bloomfeld, RS; Onken, JE. Mercaptopurine metabolite results in clinical gastroenterology practice. Alimentary Pharmacology and Therapeutics. 2003;17:69-73. (2003) Abstract

Onken, JE; Friedman, JY; Subramanian, S; Weinfurt, KP; Reed, SD; Malenbaum, JH; Schmidt, T; Schulman, KA. Treatment patterns and costs associated with sessile colorectal polyps. American Journal of Gastroenterology. 2002;97:2896-2901. (2002) Abstract

Eloubeidi, MA; Onken, JE. Manifestations of Crohn's disease. Digestive Diseases: clinical reviews. 1998;16:262. (1998) Abstract

Provenzale, D; Wong, JB; Onken, JE; Lipscomb, J. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. American Journal of Gastroenterology. 1998;93:872-880. (1998) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Dec. 12, 2006
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/jane_e_onken